Pseudophenomena, that is, imaging alterations due to therapy rather than tumor evolution,
have an important impact on the management of glioma patients and the results of clinical …

Pseudoprogression (PsP) refers to treatment‐related clinico‐radiologic changes mimicking
true progression (TP) that occurs in patients with glioblastoma (GBM), predominantly within …

Alternating electric field therapy has been approved for glioblastoma (GBM). We have
preclinical evidence for anticancer effects in GBM cell cultures and mouse xenografts with …

Purpose We propose three support vector machine (SVM) classifiers, using pre-and post-
contrast T2 fluid-attenuated inversion recovery (FLAIR) subtraction and/or pre-and post …

Objective With the discovery that familial phaeochromocytoma and paraganglioma
syndrome can be caused by mutations in each subunit of the succinate dehydrogenase …

Despite decades of advancement in the diagnosis and therapy of gliomas, the most
malignant primary brain tumors, the overall survival rate is still dismal, and their post …

Gliomas are the commonest malignant central nervous system tumours in adults and
imaging is the cornerstone of diagnosis, treatment, and post-treatment follow-up of these …

Glioblastoma (GBM) is the most malignant brain tumor in adults, with a dismal prognosis
despite aggressive multi-modal therapy. Immunotherapy is currently being evaluated as an …

When applying electroporation to the brain, it is important to understand the effects on the
blood-brain barrier (BBB) and brain vasculature. Here we studied the effects of point-source …

Purpose Our systematic review and meta-analysis aimed to evaluate the diagnostic
performance of [18F] FDG PET/MRI vs.[18F] FET PET/MRI for recurrent glioma. Methods We …